Prepare with focused SCFHS Neurology exam mcqs covering the areas listed in the official SCFHS examination guideline. Practice Saudi Neurology Prometric Exam test under timed conditions, review detailed explanations, identify weak topics, and build confidence before exam day.
Start PracticePrometricDr's SCFHS Neurology practice test helps you assess your clinical knowledge across the major areas covered in the SCFHS examination. Practice exam style Saudi Neurology Prometric Exam multiple choice questions, review explanations, monitor your results, and use your performance to determine where further study is needed.
Best for candidates who are already preparing and want focused practice before exam day.
Ideal for candidates who want enough time to practice, review weak areas, and improve consistently.
Best for candidates who want maximum flexibility, long-term access, and plenty of time to prepare without rushing.
Whether you are starting your preparation or getting ready for another attempt, PrometricDr gives you a structured way to test your knowledge, strengthen weak areas, and build SCFHS Neurology exam readiness.
Candidates need a focused study approach that fits around their duties, personal commitments, and limited preparation time.
PrometricDr is designed to make SCFHS exam preparation more practical, structured, and consistent from your first study session through to exam day. This platform helps you maintain a clear study routine, stay engaged with relevant prep material, and approach your Saudi Neurology Prometric Exam with greater preparation and confidence.
Work through targeted Saudi Neurology Prometric Exam questions across important topics instead of spending time on random material.
Work through timed SCFHS Neurology practice test to improve pacing, concentration, and question management.
See your results immediately, review explanations, and discover which areas need more attention before your next attempt.
Doctors Prepared
Mock Tests Available
Specialties Covered
Exam Focused Accuracy
The Saudi Commission for Health Specialties (SCFHS) conducts this computer-based licensing assessment for physicians seeking professional classification as a Neurology Registrar or Senior Registrar across tertiary medical cities, specialized neuroscience institutes, and hospital inpatient units throughout the Kingdom of Saudi Arabia. The examination assesses localization-driven neurological examination, emergency stroke interventions, epilepsy pharmacotherapy, neuromuscular diagnostic tests, and neuro-critical care management. Once clinical credentials, residency records, and DataFlow primary source verification receive final approval, candidates obtain test scheduling clearance via the SCFHS Mumaris+ portal.
|
Exam Parameter |
Details |
|
Exam Title |
Saudi Neurology Prometric Exam (Neurology Specialist / Registrar) |
|
Authority |
Saudi Commission for Health Specialties (SCFHS) |
|
Delivery Mode |
Prometric Computer-Based Test (CBT) |
|
Exam Code |
NEUR-REG / NEUR |
|
Question Format |
Multiple-Choice (Single Best Answer) |
|
Number of MCQs |
150 to 200 questions (administered in 2 clinical sections) |
|
Exam Duration |
3.5 to 4 hours (with a scheduled 30-minute midpoint break) |
|
Passing Score |
65% for Registrar; 70% for Senior Registrar |
|
Negative Marking |
None |
|
Language |
English |
|
Score Result |
Pass / Fail report accessible via the Mumaris+ portal within 7 to 10 working days |
|
Score Validity |
5 years |
The examination blueprint tests anatomical lesion localization, diagnostic neuroimaging (MRI/CT), neurophysiology studies (EEG, EMG, NCS), and evidence-based therapeutic interventions. Questions focus on acute vascular emergencies, complex epilepsy management, neuro-immunological disorders, and progressive neurodegenerative diseases aligned with international clinical neurological practice guidelines.
|
Specialty Module |
Core Topics |
Key Focus Areas & Clinical Scenarios |
|
Cerebrovascular Diseases & Stroke |
Acute ischemic stroke, transient ischemic attack (TIA), large vessel occlusion (LVO), intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), and cerebral venous sinus thrombosis (CVST). |
Thrombolysis (IV alteplase/tenecteplase) eligibility within 4.5 hours, mechanical thrombectomy window selection via ASPECTS score, blood pressure targets in acute ICH, and anticoagulation timing in CVST. |
|
Epilepsy, Paroxysmal Disorders & Sleep |
Focal vs. generalized seizures, status epilepticus protocols, anti-seizure medication (ASM) pharmacokinetics, EEG pattern interpretation, and sleep disorders (narcolepsy, OSA). |
Stepwise pharmacotherapy for convulsive status epilepticus, teratogenic risks of valproate in women of childbearing potential, identifying periodic lateralized epileptiform discharges (PLEDs), and non-epileptic event workup. |
|
Neuromuscular & Peripheral Nerve Disorders |
Amyotrophic lateral sclerosis (ALS), Guillain-Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, Lambert-Eaton syndrome, and muscular dystrophies. |
Interpreting nerve conduction studies (conduction block, prolonged F-waves), managing acute myasthenic crises with plasmapheresis or IVIG, monitoring forced vital capacity (FVC), and repetitive nerve stimulation findings. |
|
Demyelinating Disorders & Multiple Sclerosis |
Relapsing-remitting multiple sclerosis (RRMS), primary progressive MS, neuromyelitis optica spectrum disorder (NMOSD), MOG antibody-associated disease (MOGAD), and acute disseminated encephalomyelitis (ADEM). |
McDonald diagnostic criteria (dissemination in time and space), differentiating anti-AQP4 NMOSD from classic MS on MRI spine/brain, acute relapse pulse-steroid therapy, and disease-modifying therapy selection (B-cell depletors, natalizumab). |
|
Movement Disorders |
Parkinson’s disease, atypical parkinsonism (MSA, PSP, CBD), Huntington’s disease, essential tremor, dystonias, and drug-induced movement disorders (tardive dyskinesia, NMS). |
Managing motor fluctuations and levodopa-induced dyskinesias, differentiating PSP (hummingbird sign) from idiopathic PD, deep brain stimulation (DBS) eligibility, and botulinum toxin clinical applications. |
|
Cognitive Disorders & Dementias |
Alzheimer’s disease, vascular dementia, dementia with Lewy bodies (DLB), frontotemporal dementia (FTD), normal pressure hydrocephalus (NPH), and prion diseases (Creutzfeldt-Jakob disease). |
Clinical differentiation of behavioral-variant FTD from early Alzheimer’s, cholinergic therapy monitoring, identifying visual hallucinations and neuroleptic hypersensitivity in DLB, and classic triad evaluation in NPH. |
|
Headache & Facial Pain Syndromes |
Migraine (episodic, chronic, with aura), tension-type headache, cluster headache, trigeminal neuralgia, and idiopathic intracranial hypertension (IIH). |
CGRP-targeting antagonists for migraine prevention, high-flow oxygen for acute cluster attacks, funduscopic evaluation for papilledema, lumbar puncture opening pressure in IIH, and medical vs. microvascular decompression in trigeminal neuralgia. |
|
CNS Infections & Neuro-Inflammation |
Bacterial, viral, and fungal meningitis, herpes simplex encephalitis (HSE), neurosyphilis, neurotuberculosis, brain abscesses, and autoimmune encephalitis (anti-NMDA receptor). |
CSF profile analysis (opening pressure, protein, glucose ratio, oligoclonal bands), empiric antimicrobial regimens for acute bacterial meningitis, temporal lobe MRI findings in HSE, and autoimmune antibody testing. |
|
Neuro-Ophthalmology & Cranial Nerves |
Optic neuritis, ischemic optic neuropathies (arteritic vs. non-arteritic), Horner syndrome, third, fourth, and sixth cranial nerve palsies, and vestibular schwannoma. |
Differentiating pupil-sparing from pupil-involving third nerve palsy (aneurysm exclusion), relative afferent pupillary defect (RAPD) assessment, and localizing lesions within the cavernous sinus vs. orbital apex. |
|
Neuro-Oncology & Systemic Neurology |
Primary brain tumors (gliomas, meningiomas), brain metastases, paraneoplastic neurological syndromes, metabolic encephalopathies (hepatic, uremic), and Wernicke-Korsakoff syndrome. |
Managing elevated ICP with hyperosmolar therapy (hypertonic saline, mannitol), paraneoplastic onconeural antibody profiling, early IV thiamine before glucose administration, and seizure prophylaxis in primary brain tumors. |
|
Trauma, Critical Care & Professional Ethics |
Traumatic brain injury (GCS scoring, diffuse axonal injury), spinal cord injury (ASIA classification), brain death determination protocols, informed consent, and SCFHS regulations. |
Systematic clinical brain death testing (apnea test criteria, confounding factor exclusion), ICP monitor indications, ethical withdrawal-of-life-support pathways, and Saudi healthcare legislation compliance. |
Copyright © 2026 PrometricDr. All Rights Reserved